Risk Factors for Early Death Following Conventional Chemotherapy

Purpose: To evaluate a patient who is starting chemotherapy for risk factors associated with early death based on the report of Ray-Coquard et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient who is starting cancer hemotherapy?

Yes

White blood cell count

Percent lymphocytes in the differential count (enter from 0 to 100)

Performance status

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Absolute lymphocyte count

Number of risk factors for early death

Estimated percent of patients with these features dying within 31 days of chemotherapy

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Criteria For Diagnosis
- Advanced Stage Hodgkin Disease | Score for Treatment-Related Mortality (TRM)
Severity, Prognosis, Stage
- Tool for Predicting Acute Chemotherapy-Induced Nausea and Vomiting (CINV)
- Advanced Stage Hodgkin Disease | Score for Treatment-Related Mortality (TRM)
Complications
- Tool for Predicting Acute Chemotherapy-Induced Nausea and Vomiting (CINV)
- Symptom Profile in Patients Receiving Radiation Therapy

Therapy

Selection
- Anticipatory Nausea Index for Cancer Chemotherapy
Dosage Calculations
- Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial
Prevention
- Emetic Effect of Chemotherapeutic Agents

Monitoring

Response To Therapy
Adverse Effects
Drug Levels
- Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial
Overdose And Reversal
- Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial

Specialty

Hematology Oncology
Pharmacology, clinical

Objective

risk factors
complications
response to therapy

ICD-10

Y43.3 - Adverse effects in therapeutic use, other antineoplastic drugs

Info

Purpose: To evaluate a patient who is starting chemotherapy for risk factors associated with early death based on the report of Ray-Coquard et al.

Specialty: Hematology Oncology, Pharmacology, clinical

Objective: risk factors, complications, response to therapy

ICD-10: Y43.3,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path